Cizzle Biotechnology Holdings Plc (LON:CIZ)
2.000
-0.050 (-2.44%)
Jul 24, 2026, 4:15 PM GMT
LON:CIZ Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
8.71M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | 4.55M | -772.00K | -14.51% |
| Dec 31, 2016 | 5.32M | -1.58M | -22.92% |
| Dec 31, 2015 | 6.90M | -287.00K | -3.99% |
| Dec 31, 2014 | 7.19M | -2.24M | -23.72% |
| Dec 31, 2013 | 9.42M | 722.00K | 8.30% |
| Dec 31, 2012 | 8.70M | 2.64M | 43.56% |
| Dec 31, 2011 | 6.06M | 3.34M | 122.83% |
| Dec 31, 2010 | 2.72M | 1.16M | 74.25% |
| Dec 31, 2009 | 1.56M | -67.00K | -4.12% |
| Dec 31, 2008 | 1.63M | 1.32M | 430.27% |
| Dec 31, 2007 | 307.01K | 85.43K | 38.56% |
| Dec 31, 2006 | 221.58K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 9.76M |
| IXICO | 7.28M |
| Fusion Antibodies | 1.60M |
| Aptamer Group | 1.38M |
| Oxford BioDynamics | 1.20M |
| OptiBiotix Health | 1.17M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 231.00K |